• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于高级乳腺癌多学科诊疗团队的数字解决方案:试点应用共创与实施研究

A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study.

作者信息

Hodroj Khalil, Pellegrin David, Menard Cindy, Bachelot Thomas, Durand Thierry, Toussaint Philippe, Dufresne Armelle, Mery Benoite, Tredan Olivier, Goulvent Thibaut, Heudel Pierre

机构信息

Centre Leon Berard, Lyon, France.

Roche Healthcare Development Division - Roche Diagnostics France, Meylan, Meylan, France.

出版信息

JMIR Cancer. 2023 May 18;9:e39072. doi: 10.2196/39072.

DOI:10.2196/39072
PMID:37200077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10236276/
Abstract

BACKGROUND

Cancer treatment is constantly evolving toward a more personalized approach based on clinical features, imaging, and genomic pathology information. To ensure the best care for patients, multidisciplinary teams (MDTs) meet regularly to review cases. Notwithstanding, the conduction of MDT meetings is challenged by medical time restrictions, the unavailability of critical MDT members, and the additional administrative work required. These issues may result in members missing information during MDT meetings and postponed treatment. To explore and facilitate improved approaches for MDT meetings in France, using advanced breast cancers (ABCs) as a model, Centre Léon Bérard (CLB) and ROCHE Diagnostics cocreated an MDT application prototype based on structured data.

OBJECTIVE

In this paper, we want to describe how an application prototype was implemented for ABC MDT meetings at CLB to support clinical decisions.

METHODS

Prior to the initiation of cocreation activities, an organizational audit of ABC MDT meetings identified the following four key phases for the MDT: the instigation, preparation, execution, and follow-up phases. For each phase, challenges and opportunities were identified that informed the new cocreation activities. The MDT application prototype became software that integrated structured data from medical files for the visualization of the neoplastic history of a patient. The digital solution was assessed via a before-and-after audit and a survey questionnaire that was administered to health care professionals involved in the MDT.

RESULTS

The ABC MDT meeting audit was carried out during 3 MDT meetings, including 70 discussions of clinical cases before and 58 such discussions after the implementation of the MDT application prototype. We identified 33 pain points related to the preparation, execution, and follow-up phases. No issues were identified related to the instigation phase. Difficulties were grouped as follows: process challenges (n=18), technological limitations (n=9), and the lack of available resources (n=6). The preparation of MDT meetings was the phase in which the most issues (n=16) were seen. A repeat audit, which was undertaken after the implementation of the MDT application, demonstrated that (1) the discussion times per case remained comparable (2 min and 22 s vs 2 min and 14 s), (2) the capture of MDT decisions improved (all cases included a therapeutic proposal), (3) there was no postponement of treatment decisions, and (4) the mean confidence of medical oncologists in decision-making increased.

CONCLUSIONS

The introduction of the MDT application prototype at CLB to support the ABC MDT seemed to improve the quality of and confidence in clinical decisions. The integration of an MDT application with the local electronic medical record and the utilization of structured data conforming to international terminologies could enable a national network of MDTs to support sustained improvements to patient care.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31d/10236276/29c0fd392421/cancer_v9i1e39072_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31d/10236276/29c0fd392421/cancer_v9i1e39072_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31d/10236276/29c0fd392421/cancer_v9i1e39072_fig1.jpg
摘要

背景

癌症治疗正不断朝着基于临床特征、影像学和基因组病理学信息的更个性化方法发展。为确保为患者提供最佳护理,多学科团队(MDT)定期开会以审查病例。尽管如此,MDT会议的开展受到医疗时间限制、关键MDT成员无法到场以及所需额外行政工作的挑战。这些问题可能导致成员在MDT会议期间错过信息以及治疗延迟。为探索并促进法国MDT会议的改进方法,以晚期乳腺癌(ABC)为模型,里昂贝拉尔中心(CLB)和罗氏诊断公司共同创建了一个基于结构化数据的MDT应用程序原型。

目的

在本文中,我们想描述CLB如何为ABC的MDT会议实施一个应用程序原型以支持临床决策。

方法

在共同创建活动开始之前,对ABC的MDT会议进行了组织审计,确定了MDT的以下四个关键阶段:发起、准备、执行和跟进阶段。对于每个阶段,确定了挑战和机遇,为新的共同创建活动提供了依据。MDT应用程序原型变成了一个软件,该软件整合了来自医疗档案的结构化数据,用于可视化患者的肿瘤病史。通过前后审计以及向参与MDT的医疗保健专业人员发放调查问卷来评估该数字解决方案。

结果

在3次MDT会议期间进行了ABC的MDT会议审计,包括MDT应用程序原型实施前对70个临床病例的讨论和实施后对58个此类病例的讨论。我们确定了与准备、执行和跟进阶段相关的33个痛点。未发现与发起阶段相关的问题。困难分为以下几类:流程挑战(n = 18)、技术限制(n = 9)和可用资源不足(n = 6)。MDT会议的准备阶段是出现问题最多(n = 16)的阶段。在应用程序实施后进行的重复审计表明:(1)每个病例的讨论时间保持相当(2分22秒对2分14秒);(2)MDT决策的记录有所改善(所有病例都包括治疗建议);(3)治疗决策没有延迟;(4)肿瘤内科医生决策的平均信心有所提高。

结论

在CLB引入MDT应用程序原型以支持ABC的MDT似乎提高了临床决策的质量和信心。将MDT应用程序与本地电子病历集成,并利用符合国际术语的结构化数据,可能会形成一个全国性的MDT网络,以支持持续改善患者护理。

相似文献

1
A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study.一种用于高级乳腺癌多学科诊疗团队的数字解决方案:试点应用共创与实施研究
JMIR Cancer. 2023 May 18;9:e39072. doi: 10.2196/39072.
2
3
"No decision about me without me" in the context of cancer multidisciplinary team meetings: a qualitative interview study.癌症多学科团队会议背景下的“没有我参与就没有关于我的决定”:一项定性访谈研究
BMC Health Serv Res. 2014 Oct 24;14:488. doi: 10.1186/s12913-014-0488-2.
4
Strategies to improve the efficiency and utility of multidisciplinary team meetings in urology cancer care: a survey study.提高泌尿外科癌症护理多学科团队会议效率和效用的策略:一项调查研究。
BMC Health Serv Res. 2014 Sep 8;14:377. doi: 10.1186/1472-6963-14-377.
5
Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change.癌症多学科团队会议的实际情况:一项多机构定量调查的结果及对政策变革的启示。
Asia Pac J Clin Oncol. 2018 Feb;14(1):74-83. doi: 10.1111/ajco.12765. Epub 2017 Sep 26.
6
Contributions to Multidisciplinary Team Meetings in Cancer Care: Predictors of Complete Case Information and Comprehensive Case Discussions.对癌症护理多学科团队会议的贡献:完整病例信息和全面病例讨论的预测因素。
J Multidiscip Healthc. 2021 Sep 4;14:2445-2452. doi: 10.2147/JMDH.S309162. eCollection 2021.
7
Cancer multidisciplinary team meetings: impact of logistical challenges on communication and decision-making.癌症多学科团队会议:后勤挑战对沟通和决策的影响。
BJS Open. 2022 Jul 7;6(4). doi: 10.1093/bjsopen/zrac093.
8
Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: an interview study of the provider perspective.影响癌症多学科团队决策和决策实施的因素:提供者视角的访谈研究。
Int J Surg. 2013;11(5):389-94. doi: 10.1016/j.ijsu.2013.02.026. Epub 2013 Mar 14.
9
Determinants of treatment plan implementation in multidisciplinary team meetings for patients with chronic diseases: a mixed-methods study.慢性病患者多学科团队会议中治疗计划实施的决定因素:一项混合方法研究。
BMJ Qual Saf. 2014 Oct;23(10):867-76. doi: 10.1136/bmjqs-2014-002818. Epub 2014 Jun 9.
10
Investigating the efficiency of lung multi-disciplinary team meetings-A mixed methods study of eight lung multi-disciplinary teams.调查肺多学科团队会议的效率-对 8 个肺多学科团队的混合方法研究。
Cancer Med. 2023 Apr;12(8):9999-10007. doi: 10.1002/cam4.5730. Epub 2023 Mar 19.

引用本文的文献

1
The Use of an Integrated Digital Tool to Improve the Efficiency of Multidisciplinary Tumor Boards-A Prospective Trial in Taiwan.使用整合数字工具提高多学科肿瘤病例讨论会的效率——台湾的一项前瞻性试验
Cancers (Basel). 2025 Jan 28;17(3):444. doi: 10.3390/cancers17030444.
2
Mixed Reality as a Digital Visualisation Solution for the Head and Neck Tumour Board: Application Creation and Implementation Study.混合现实作为头颈肿瘤多学科会诊的数字可视化解决方案:应用创建与实施研究
Cancers (Basel). 2024 Mar 31;16(7):1392. doi: 10.3390/cancers16071392.

本文引用的文献

1
An Integrated Care Platform System (C3-Cloud) for Care Planning, Decision Support, and Empowerment of Patients With Multimorbidity: Protocol for a Technology Trial.用于合并症患者护理计划、决策支持及赋能的综合护理平台系统(C3-Cloud):一项技术试验方案
JMIR Res Protoc. 2022 Jul 13;11(7):e21994. doi: 10.2196/21994.
2
Multidisciplinary team meeting as a highly recommended EUSOMA criteria evaluating the quality of breast cancer management between centers.多学科团队会议是一项备受推荐的欧洲乳腺外科协会(EUSOMA)标准,用于评估各中心乳腺癌管理的质量。
Breast. 2021 Dec;60:310. doi: 10.1016/j.breast.2021.11.001. Epub 2021 Nov 3.
3
Multidisciplinary team meetings: are all patients presented and does it impact quality of care and survival - a registry-based study.
多学科团队会议:是否所有患者都得到了介绍,以及它是否会影响护理质量和生存率 - 一项基于登记的研究。
BMC Health Serv Res. 2021 Oct 1;21(1):1032. doi: 10.1186/s12913-021-07022-x.
4
A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study.基于智能手机的应用程序改善早期乳腺癌患者多学科决策辅助治疗依从性的观察性研究。
J Med Internet Res. 2021 Sep 16;23(9):e27576. doi: 10.2196/27576.
5
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer.激素受体阳性早期乳腺癌中 HER2 低表达的预后影响。
Breast. 2021 Dec;60:62-69. doi: 10.1016/j.breast.2021.08.016. Epub 2021 Aug 26.
6
The Effects of Multidisciplinary Team Meetings on Clinical Practice for Colorectal, Lung, Prostate and Breast Cancer: A Systematic Review.多学科团队会议对结直肠癌、肺癌、前列腺癌和乳腺癌临床实践的影响:一项系统评价
Cancers (Basel). 2021 Aug 18;13(16):4159. doi: 10.3390/cancers13164159.
7
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival.在 MONALEESA-3 期随机对照试验中,对于激素受体阳性、人表皮生长因子受体 2 阴性的绝经后妇女的晚期乳腺癌,来曲唑联合氟维司群治疗:更新的总生存数据。
Ann Oncol. 2021 Aug;32(8):1015-1024. doi: 10.1016/j.annonc.2021.05.353. Epub 2021 Jun 5.
8
Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors.曲妥珠单抗-德曲妥珠单抗:改变 HER2 表达实体瘤的命运。
Int J Mol Sci. 2021 Apr 30;22(9):4774. doi: 10.3390/ijms22094774.
9
OSIRIS: A Minimum Data Set for Data Sharing and Interoperability in Oncology.OSIRIS:肿瘤学中用于数据共享和互操作的最小数据集。
JCO Clin Cancer Inform. 2021 Mar;5:256-265. doi: 10.1200/CCI.20.00094.
10
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.帕博西尼联合内分泌治疗用于激素受体阳性/人表皮生长因子受体 2 阴性晚期乳腺癌的长期 pooled 安全性分析:最多 5 年随访的更新分析。
Oncologist. 2021 May;26(5):e749-e755. doi: 10.1002/onco.13684. Epub 2021 Mar 10.